Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning.
Saved in:
| Title: | Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning. |
|---|---|
| Authors: | Nippa DF; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany., Atz K; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland., Hohler R; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Müller AT; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Marx A; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Bartelmus C; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wuitschik G; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Marzuoli I; Process Chemistry and Catalysis (PCC), F. Hoffmann-La Roche Ltd., Basel, Switzerland., Jost V; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wolfard J; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Binder M; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Stepan AF; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Konrad DB; Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany. david.konrad@cup.lmu.de., Grether U; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. uwe.grether@roche.com., Martin RE; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. rainer_e.martin@roche.com., Schneider G; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland. gisbert@ethz.ch.; ETH Singapore SEC Ltd, Singapore, Singapore. gisbert@ethz.ch. |
| Source: | Nature chemistry [Nat Chem] 2024 Feb; Vol. 16 (2), pp. 239-248. Date of Electronic Publication: 2023 Nov 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101499734 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-4349 (Electronic) Linking ISSN: 17554330 NLM ISO Abbreviation: Nat Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37996732 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nippa+DF%22">Nippa DF</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Atz+K%22">Atz K</searchLink>; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hohler+R%22">Hohler R</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Müller+AT%22">Müller AT</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marx+A%22">Marx A</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bartelmus+C%22">Bartelmus C</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wuitschik+G%22">Wuitschik G</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marzuoli+I%22">Marzuoli I</searchLink>; Process Chemistry and Catalysis (PCC), F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jost+V%22">Jost V</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wolfard+J%22">Wolfard J</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Binder+M%22">Binder M</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stepan+AF%22">Stepan AF</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Konrad+DB%22">Konrad DB</searchLink>; Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany. david.konrad@cup.lmu.de.<br /><searchLink fieldCode="AU" term="%22Grether+U%22">Grether U</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. uwe.grether@roche.com.<br /><searchLink fieldCode="AU" term="%22Martin+RE%22">Martin RE</searchLink>; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. rainer&#95;e.martin@roche.com.<br /><searchLink fieldCode="AU" term="%22Schneider+G%22">Schneider G</searchLink>; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland. gisbert@ethz.ch.; ETH Singapore SEC Ltd, Singapore, Singapore. gisbert@ethz.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101499734%22">Nature chemistry</searchLink> [Nat Chem] 2024 Feb; Vol. 16 (2), pp. 239-248. <i>Date of Electronic Publication: </i>2023 Nov 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101499734 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1755-4349 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217554330%22">17554330 </searchLink><i>NLM ISO Abbreviation: </i>Nat Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37996732 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41557-023-01360-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 239 Titles: – TitleFull: Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nippa DF – PersonEntity: Name: NameFull: Atz K – PersonEntity: Name: NameFull: Hohler R – PersonEntity: Name: NameFull: Müller AT – PersonEntity: Name: NameFull: Marx A – PersonEntity: Name: NameFull: Bartelmus C – PersonEntity: Name: NameFull: Wuitschik G – PersonEntity: Name: NameFull: Marzuoli I – PersonEntity: Name: NameFull: Jost V – PersonEntity: Name: NameFull: Wolfard J – PersonEntity: Name: NameFull: Binder M – PersonEntity: Name: NameFull: Stepan AF – PersonEntity: Name: NameFull: Konrad DB – PersonEntity: Name: NameFull: Grether U – PersonEntity: Name: NameFull: Martin RE – PersonEntity: Name: NameFull: Schneider G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1755-4349 Numbering: – Type: volume Value: 16 – Type: issue Value: 2 Titles: – TitleFull: Nature chemistry Type: main |
| ResultId | 1 |